The rise of theranostics: Part 4 -- Women's theranostics on the horizon
AuntMinnie
JULY 8, 2024
With CAM-H2, we engineered the protein to bind to a different epitope on HER2 to other approved therapies, so the option of combining CAM-H2 with other therapies is definitely an opportunity." Both groups would undergo standard of care imaging, or CT and bone scan, or FDG PET/CT, or FES PET/CT.
105 
Let's personalize your content